DRUG

dual inhibitors

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for dual inhibitors

Pancreatic cancer 1

Mediator Outcome Score Tier Lit. status Trial
EGFR pancreatic ductal adenocarcinoma 0.208 Mid partial evidence preclinical only

Clinical trials

200 registered trials for dual inhibitors

Source: ClinicalTrials.gov

← All drugs